Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
alleviate, Almagor, Amnon, answer, Appling, bought, Brightman, Canndoc, CDMO, clean, comapny, comprehended, Concomitantly, CVI, Deloitte, desired, disagreement, disclaimer, eliciting, Empry, expiry, EY, FasCellect, FasLfor, floating, fourteen, fruition, gamma, gel, GMP, Goldyne, hampered, haploidentical, hexamer, hFasL, Hubei, IMCA, inexpensive, interferon, invitro, Korst, LOI, mg, mid, mitochondrial, Monthey, Myeloid, naive, opioid, outbreak, pandemic, prefunded, Province, Rahamim, reconfirmed, Rheumatoid, RMAT, satisfactorily, Savad, score, Sivan, swelling, teamwork, tox, unconditional, upto, vacation, WU, Wuhan, Xiang, Zhifu, Zohar
Removed:
Africa, authored, Berelowtiz, biomedical, BioSight, Brook, businessman, carryforward, chaired, College, Consul, Council, CPI, credited, cum, cycle, Dazzi, derecognition, diverse, editorial, eighteen, Endocrine, Endocrinology, enforceable, entrepreneur, Fax, Francesco, Haematological, Honorary, hormone, intangible, intention, journal, KHP, King, laude, Leadcom, London, Mt, neutralizing, NIH, Oramed, Pfizer, PhD, pituitary, Procognia, profitably, Recro, reliably, remeasure, remeasurement, renewable, restatement, SHL, SHLTN, Stony, SUNY, Tanzania, Task, thing, thousand, Thrombotech, YEDA, yielded
Filing tables
Filing exhibits
- 20-F Annual report (foreign)
- 2.5 Description of Securities
- 8.1 Subsidiaries of Cellect Biotechnology LTD.
- 12.1 Certification
- 12.2 Certification
- 13.1 Certification
- 13.2 Certification
- 15.1 Consent of Korst Forer Gabbay & Kasierer, Certified Public Accountants (Isr.), a Member of Ernst & Young Global
- 15.2 Consent of Brightman Almagor Zohar & Co., Certified Public Accountants (Isr.), a Firm In the Deloitte Global Network
- 16.1 Consent of Korst Forer Gabbay & Kasierer, Certified Public Accountants (Isr.), a Member of Ernst & Young Global
- Download Excel data file
- View Excel data file
QNRX similar filings
Filing view
External links
Exhibit 13.1
CERTIFICATION PURSUANT TO
18 U.S.C. Section 1350
In connection with the filing of the Annual Report on Form 20-F for the period ended December 31, 2019 (the “Report”) by Cellect Biotechnology Ltd. (the "Company"), the undersigned, as Chief Executive Officer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
(1) the Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: April 3, 2020
/s/ Shai Yarkoni | |
Name: Shai Yarkoni | |
Title: Chief Executive Officer |